CareMax, Inc. (CMAX)
- Previous Close
2.7700 - Open
2.7600 - Bid 2.0600 x 200
- Ask 3.6600 x 200
- Day's Range
2.7000 - 2.9900 - 52 Week Range
2.2350 - 126.0000 - Volume
16,060 - Avg. Volume
77,116 - Market Cap (intraday)
10.99M - Beta (5Y Monthly) 0.88
- PE Ratio (TTM)
-- - EPS (TTM)
-172.6700 - Earnings Date Aug 7, 2024 - Aug 12, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
33.60
CareMax, Inc. provides care and chronic disease management services through physicians and health care professionals. It offers a suite of health care and social services to its patients, including primary care, specialty care, telemedicine, health and wellness, optometry, dental, pharmacy, and transportation; and services to children and adults through Medicaid programs, as well as through commercial insurance plans. The company also provides CareOptimize, a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians in the United States. It operates multi-specialty medical care centers in Florida, New York, Tennessee, and Texas. The company is headquartered in Miami, Florida.
www.caremax.com1,450
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: CMAX
Performance Overview: CMAX
Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CMAX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CMAX
Valuation Measures
Market Cap
10.99M
Enterprise Value
474.09M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.01
Price/Book (mrq)
0.54
Enterprise Value/Revenue
0.58
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-79.55%
Return on Assets (ttm)
-8.76%
Return on Equity (ttm)
-230.17%
Revenue (ttm)
810.36M
Net Income Avi to Common (ttm)
-644.67M
Diluted EPS (ttm)
-172.6700
Balance Sheet and Cash Flow
Total Cash (mrq)
41.48M
Total Debt/Equity (mrq)
2,467.05%
Levered Free Cash Flow (ttm)
20.88M
Research Analysis: CMAX
Company Insights: CMAX
CMAX does not have Company Insights